BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 9820484)

  • 1. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
    Onodera K; Hancock WW; Graser E; Lehmann M; Sayegh MH; Strom TB; Volk HD; Kupiec-Weglinski JW
    J Immunol; 1997 Feb; 158(4):1572-81. PubMed ID: 9029092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains.
    Ilano AL; McConnell MV; Gurley KE; Spinelli A; Pearce NW; Hall BM
    J Immunol; 1989 Nov; 143(9):2828-36. PubMed ID: 2572644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance.
    Takeuchi T; Lowry RP; Konieczny B
    Transplantation; 1992 Jun; 53(6):1281-94. PubMed ID: 1351322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures.
    Hall BM; Robinson CM; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ
    Transpl Immunol; 2008 Feb; 18(4):291-301. PubMed ID: 18158114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J; Zhang L; Tang J; Jiang S; Wang X
    Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
    Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
    J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.
    Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM
    J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8.
    Chen Z; Cobbold S; Metcalfe S; Waldmann H
    Eur J Immunol; 1992 Mar; 22(3):805-10. PubMed ID: 1547823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
    Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L
    Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.